Skip to main content Skip to main navigation menu Skip to site footer
DTI logo
  • About
    • About the Journal
    • The Publisher
    • Editorial Masthead
    • Abstracting and indexing
    • Publication ethics
    • Copyright and Licensing
    • Privacy Statement
    • Contact
  • Editorial team
  • Policies
    • Open Access policy
    • Editorial policies
    • Self archiving and sharing policy
    • Commercial policies
    • Waiver and discount policy
    • Privacy policy
  • Guidelines
    • Guidelines for Authors
    • Guidelines for Reviewers
    • Artwork guidelines
    • Publication fees
    • Content type
  • Archives
  • Latest articles
  • Open call for papers
Search
  • Register
  • Login
  • Submit now
  1. Home /
  2. Archives /
  3. Vol. 13 No. 1 (2019): January-December 2019

Vol. 13 No. 1 (2019): January-December 2019

DOI: https://doi.org/10.1177/1177392819861987
Published: 2019-12-31

Editorial

  • Omalizumab as a Provoking Factor for Venous Thromboembolism

    Crhistian-Mario Oblitas, Francisco Galeano-Valle, Laura Vela-De La Cruz, Jorge Del Toro-Cervera, Pablo Demelo-Rodríguez
    DOI: https://doi.org/10.33393/dti.2019.1415
    • PDF

Review

  • "Basic Concepts in Genetics and Pharmacogenomics for Pharmacists"

    Kathleen B Orrico
    DOI: https://doi.org/10.33393/dti.2019.1416
    • PDF
  • Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies

    Aimi Syamima Abdul Manap, Shantini Vijayabalan, Priya Madhavan, Yoke Yin Chia, Aditya Arya, Eng Hwa Wong, Farzana Rizwan, Umesh Bindal, Shajan Koshy
    DOI: https://doi.org/10.33393/dti.2019.1417
    • PDF
  • Vernakalant in Atrial Fibrillation: A Relatively New Weapon in the Armamentarium Against an Old Enemy

    Antoine Kossaify
    DOI: https://doi.org/10.33393/dti.2019.1418
    • PDF
  • A Comprehensive Review of Pegvaliase, an Enzyme Substitution Therapy for the Treatment of Phenylketonuria

    Tasmina Hydery, Valerie Azzopardi Coppenrath
    DOI: https://doi.org/10.33393/dti.2019.1419
    • PDF

Sign up

Browse

  • Sections
    • Alternative Model Organisms
    • Antimicrobial Resistance
    • Phytotherapeutics and natural products
    • Miscellaneous

banners150

SCImago Journal & Country Rank

 

Completed peer reviews since:
June 5, 2020

  • Optimizing ChEMBL-derived QSAR models for natural flavonoid screening: chemotype-specific predictive reliability in α-glucosidase-inhibition
    271
  • In vitro and molecular docking evaluation of apigenin-7-O-glucuronide from Psorospermum febrifugum as anti-inflammatory and predicted antiplasmodial compound
    194
  • The role of patient preferences in adherence to treatment in chronic disease: a narrative review
    185
  • Molecular docking and dynamics analysis of selected phytocompounds against multi-targeted hepatocellular carcinoma
    185
  • Alternative model organisms: growing popularity, and the challenges
    177

Drug Target Insights | eISSN 1177-3928

© AboutScience Srl  | www.aboutscience.eu | VAT IT10418650965 | Privacy policy | Cookie Policy
Registered office: Via Marco Ulpio Traiano 35/D - 20149 Milan (MI) - Italy | Operational office: Via Eritrea 21 – 20157 Milan (MI) - Italy

Linkedin

Platform and workflow OJS/PKP | Hosting Archimede Informatica | Customizations e-Danex Digital Solutions

More information about the publishing system, Platform and Workflow by OJS/PKP.

Technical management by
Archimede Informatica